JHS Svendgaard Laboratories Shareholding Pattern
- Market cap
- ₹84.26 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹6.94 – ₹13.01
As of Jun 2026, promoters held 48.50% of JHS Svendgaard Laboratories, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
JHS Svendgaard Laboratories shareholding pattern — frequently asked questions
What is the promoter holding in JHS Svendgaard Laboratories?
Promoters held 48.50% of JHS Svendgaard Laboratories as of Jun 2026.
How much do FIIs hold in JHS Svendgaard Laboratories?
Foreign institutional investors held 18.40% of JHS Svendgaard Laboratories as of Jun 2026.
How much do domestic institutions hold in JHS Svendgaard Laboratories?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of JHS Svendgaard Laboratories as of Jun 2026; mutual funds alone held 8.50%.
Who owns JHS Svendgaard Laboratories?
As of Jun 2026, JHS Svendgaard Laboratories' shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
- Jupiter Life Line Hospitals Limited shareholding pattern
- Jagsonpal Pharmaceuticals Limited shareholding pattern
- Jubilant Pharmova Limited shareholding pattern
- IPCA Laboratories Limited shareholding pattern
- Kilitch Drugs (India) Limited shareholding pattern
- IOL Chemicals and Pharmaceuticals Limited shareholding pattern
Trade JHS Svendgaard Laboratories With ATS
Track JHS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.